UW Partnership with Simulab Corporation Receives $89,811 for Medical Training Technology

Simulab to commercialize medical skill evaluation software developed by University of Washington’s BioRobotics Laboratory.

SEATTLE – July 8, 2010 – Washington Technology Center has awarded $89,811 in state funding to the University of Washington to support a research collaboration with Simulab Corporation.

Simulab Corporation, a Seattle-based developer of medical and surgical simulators, is working with the BioRobotics Laboratory at the University of Washington to commercialize UW software capable of measuring hands-on surgical skills. Simulab plans to target surgical residency programs and large hospitals for the skill-evaluating simulators. In this Phase II project, UW will receive $89,811 in research and technology development funding from Washington Technology Center.

UW Professor Blake Hannaford, director of the BioRobotics Laboratory, is serving as principal investigator for the project titled, “EDGE Enhanced Surgical Skill Evaluation.”

“This project will validate unique software deployed in the EDGE platform, developed by UW and licensed by Simulab, which tracks hand motions of medical personnel while they interact with model tissues and organs,” said professor Hannaford. “The technology quantitatively matches performance to level of skill.

“Simulab is thrilled with the second round of funding support from WTC. The commercialization of EDGE will be the culmination of a long-standing collaboration between the University of Washington and Simulab. There is nothing currently available on the market to objectively evaluate and validate surgical skills, so EDGE is a crucial addition to the medical training process and we excited to be a part of it.” said Christopher Toly, Chief Executive Officer and Chief Technology Officer of Simulab.

“As our economy continues to struggle, innovative private-public partnerships like this are imperative. By leveraging more resources, we will be able to put more Washington workers back to work in living wage jobs,” state Sen. Jeanne Kohl-Welles (D-Seattle) said.

“These advancements, happening as a result of creative visionaries, the University of Washington’s world class research departments, and Washington Technology Center’s tremendously important grants represent everything we are trying to accomplish in the biotech field,” said state Rep. Reuven Carlyle (D-Seattle). “The innovation, high paying jobs, R&D ripple effect and commercialization of knowledge will improve not just Seattle but the whole world. We have all of the central ingredients to make Seattle the world’s premier hub for life science, global health, R&D commercialization and other fields representative of science in the 21st Century.”

“This is a big win for the UW and Simulab that could have huge long-term medical and economic potential,” said state Rep. Mary Lou Dickerson (D-Seattle), who represents the Seattle community where Simulab is located.

About Simulab Corporation

Simulab is a market leader in the development of realistic, portable, and affordable medical simulators and surgical simulators for a wide array of educational and medical training needs. With research and development efforts focused on anatomical realism and product innovation, Simulab has contributed significant advances to the field of medical simulation, including the TraumaMan® System, an advanced trauma surgery trainer, and the CentraLineMan System, a central venous trainer. Simulab, located in Seattle, Washington, collaborates with leading educators worldwide and bringing its specialized knowledge of materials and manufacturing processes to the medical model and simulation industry.

About the Research & Technology Development (RTD) Grant Program

Washington Technology Center competitively awards applied research funding through the Research & Technology Development Grant Program for technology projects that show strong potential for commercializing products and creating jobs in Washington. Since 1996, this state-funded program has supported 345 research commercialization projects developed between companies and non-profit research institutions. Applications for the next round of funding will be available in January 2011. More information about the research and technology development program is available online at http://www.watechcenter.org/rtd.

About Washington Technology Center

The mission of Washington Technology Center is to assist companies in the creation of innovative products and technologies that provide job opportunities for the citizens of Washington state. Through the Investing in Innovation program, Washington Technology Center provides companies with access to critical resources and support such as state and federal funding. Our 15,000-square-foot Microfabrication Laboratory provides companies and university researchers access to state-of-the-art process tools for micro-electromechanical systems (MEMS) research and product/process development. The impact of Washington Technology Center’s work has generated more than $600 million in additional investment for Washington companies and researchers. Learn more at http://www.watechcenter.org/ or call 206-685-1920.


This entry was posted in Life_Sciences, RTD, Seattle, Simulab, UW, WTC_News. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s